← Back to patent-cliff list
ApTOLL
Tier C — Watch / tradeApTOLL
aptaTargets SL
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Nucleic acid drug
Type
Targets：TLR4
Indications (approved)：Ischaemic stroke, Stroke
Regional status
US
-
EU
Phase II
2020-10-28
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of ApTOLL?
Approved indications include: Ischaemic stroke, Stroke.
When does the ApTOLL patent expire?
No public expiry year is available for ApTOLL yet; this page updates once verified.
How do I get a quote for ApTOLL intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06